OCREVUS 300 mg, solution à diluer pour perfusion

( ARTG ) OCREVUS is indicated for the treatment of patients with relapsing forms of multiple sclerosis (RMS) to del​​​‍​​‍​​​​‍​​‍‍ay the progression of physical disability and to reduce the frequency of relapse.,OCREVUS is indicated for the treatment of patients with primary progressive multiple sclerosis (PPMS) to delay the progression of physical disability